Canaccord Genuity Maintains Buy on Orthofix Medical, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Negative 59.8%

Neg 59.8% Neu 0% Pos 0%

Canaccord Genuity analyst Caitlin Burrows maintains Orthofix Medical (NASDAQ:OFIX) with a Buy and lowers the price target from $20 to $18.